Approval · Notice of Compliance 28332 · 2022
KIMMTRAK: Notice of Compliance 28332
Issued June 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28332
- Date
- June 7, 2022
- Company
- Immunocore Ireland LimitedDublin, Ireland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KIMMTRAK | 02527588 | Marketed |
Medicinal ingredients
- TEBENTAFUSP 100 MCG per 0.5ML